文献速递神经免疫认知障碍与痴呆

多发性硬化治疗反应的临床与MRI挑战

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.
PubMed 文献 · Neurology · 2018-12-26

来自MRI in MS研究组的专家小组分析已发表的多发性硬化治疗反应研究,讨论无疾病活动证据(NEDA)概念的演变及其对长期预后预测的作用,并探讨仅用MRI活动或结合临床复发与MRI活动病灶的定量评分系统在真实世界中的优缺点,同时关注更有效口服和注射药物的证据。

要点

  • 早期诊断和治疗的重要性已确立,但如何定义和监测MS治疗反应尚无共识。
  • 微小MRI活动的临床相关性存在争议,需要制定定义和监测治疗反应的推荐。
  • NEDA概念在演变,可考虑更现实的目标:微小疾病活动证据(MEDA)。

核心结论

  • 如何定义和监测MS治疗反应尚无共识,微小MRI活动的临床相关性存在争议,需要制定相关推荐。

研究设计与样本

  • MRI in MS研究组的专家小组分析和讨论了已发表的关于MS治疗反应的研究。

主要发现

  • 分析了NEDA概念的演变及其对预测长期预后的作用,包括定义更现实目标MEDA的选项。
  • 讨论了仅使用MRI活动以及结合治疗期间临床复发和MRI活动病灶的定量评分系统在真实世界中的优缺点。
  • 大多数已发表研究涉及接受干扰素-β治疗的患者,但特别关注了基于其他更有效口服和注射药物的近期研究证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Over the last few decades, the improved diagnostic criteria, the wide use of MRI, and the growing availability of effective pharmacologic treatments have led to substantial advances in the management of multiple sclerosis (MS). The importance of early diagnosis and treatment is now well-established, but there is still no consensus on how to define and monitor response to MS treatments. In particular, the clinical relevance of the detection of minimal MRI activity is controversial and recommendations on how to define and monitor treatment response are warranted. An expert panel of the Magnetic Resonance Imaging in MS Study Group analyzed and discussed published studies on treatment response in MS. The evolving concept of no evidence of disease activity and its effect on predicting long-term prognosis was examined, including the option of defining a more realistic target for daily clinical practice: minimal evidence of disease activity. Advantages and disadvantages associated with the use of MRI activity alone and quantitative scoring systems combining on-treatment clinical relapses and MRI active lesions to detect treatment response in the real-world setting were also discussed. While most published studies on this topic involved patients treated with interferon-β, special attention was given to more recent studies providing evidence based on treatment with other and more efficacious oral and injectable drugs. Finally, the panel identified future directions to pursue in this research field.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Gasperini C, Prosperini L, Tintoré M, et al. Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge. Neurology. 2018. PMID: 30587516. doi:10.1212/WNL.0000000000006810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。